NM_021098.3:c.1513C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021098.3(CACNA1H):​c.1513C>T​(p.Arg505Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00122 in 1,544,942 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R505H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0063 ( 7 hom., cov: 34)
Exomes 𝑓: 0.00066 ( 9 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

7
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.32

Publications

2 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0065402985).
BP6
Variant 16-1201963-C-T is Benign according to our data. Variant chr16-1201963-C-T is described in ClinVar as Benign. ClinVar VariationId is 460049.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0063 (960/152312) while in subpopulation AFR AF = 0.022 (913/41566). AF 95% confidence interval is 0.0208. There are 7 homozygotes in GnomAd4. There are 462 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 960 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
NM_021098.3
MANE Select
c.1513C>Tp.Arg505Cys
missense
Exon 9 of 35NP_066921.2
CACNA1H
NM_001005407.2
c.1513C>Tp.Arg505Cys
missense
Exon 9 of 34NP_001005407.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
ENST00000348261.11
TSL:1 MANE Select
c.1513C>Tp.Arg505Cys
missense
Exon 9 of 35ENSP00000334198.7
CACNA1H
ENST00000569107.6
TSL:1
c.1513C>Tp.Arg505Cys
missense
Exon 9 of 34ENSP00000454990.2
CACNA1H
ENST00000711493.1
c.1513C>Tp.Arg505Cys
missense
Exon 9 of 34ENSP00000518778.1

Frequencies

GnomAD3 genomes
AF:
0.00631
AC:
960
AN:
152194
Hom.:
7
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0220
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00479
GnomAD2 exomes
AF:
0.00141
AC:
200
AN:
141502
AF XY:
0.00102
show subpopulations
Gnomad AFR exome
AF:
0.0228
Gnomad AMR exome
AF:
0.00139
Gnomad ASJ exome
AF:
0.000856
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000773
Gnomad OTH exome
AF:
0.000718
GnomAD4 exome
AF:
0.000665
AC:
926
AN:
1392630
Hom.:
9
Cov.:
36
AF XY:
0.000541
AC XY:
371
AN XY:
686266
show subpopulations
African (AFR)
AF:
0.0215
AC:
677
AN:
31484
American (AMR)
AF:
0.00171
AC:
61
AN:
35584
Ashkenazi Jewish (ASJ)
AF:
0.00116
AC:
29
AN:
25092
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35614
South Asian (SAS)
AF:
0.000139
AC:
11
AN:
79114
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45928
Middle Eastern (MID)
AF:
0.00144
AC:
8
AN:
5558
European-Non Finnish (NFE)
AF:
0.0000297
AC:
32
AN:
1076452
Other (OTH)
AF:
0.00187
AC:
108
AN:
57804
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
64
129
193
258
322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00630
AC:
960
AN:
152312
Hom.:
7
Cov.:
34
AF XY:
0.00620
AC XY:
462
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0220
AC:
913
AN:
41566
American (AMR)
AF:
0.00157
AC:
24
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68010
Other (OTH)
AF:
0.00474
AC:
10
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
48
96
145
193
241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000496
Hom.:
0
Bravo
AF:
0.00701
ESP6500AA
AF:
0.0135
AC:
48
ESP6500EA
AF:
0.000141
AC:
1
ExAC
AF:
0.000893
AC:
49
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
CACNA1H-related disorder (1)
-
-
1
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Uncertain
-0.080
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.47
T
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.069
N
LIST_S2
Benign
0.82
T
MetaRNN
Benign
0.0065
T
MetaSVM
Uncertain
0.27
D
MutationAssessor
Uncertain
2.2
M
PhyloP100
1.3
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-2.2
N
REVEL
Uncertain
0.40
Sift
Benign
0.036
D
Sift4G
Uncertain
0.047
D
Polyphen
1.0
D
Vest4
0.34
MVP
0.88
ClinPred
0.019
T
GERP RS
-0.56
Varity_R
0.081
gMVP
0.44
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60414549; hg19: chr16-1251963; COSMIC: COSV107431089; COSMIC: COSV107431089; API